AngioDynamics to Pre
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
06 sept. 2016 08h37 HE | AngioDynamics
ALBANY, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Pre
AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
08 août 2016 14h30 HE | AngioDynamics
ALBANY, N.Y., Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Announ
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
01 août 2016 16h30 HE | AngioDynamics
ALBANY, N.Y., Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Appoin
AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
25 juil. 2016 07h34 HE | AngioDynamics
ALBANY, N.Y., July 25, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Report
AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
13 juil. 2016 06h00 HE | AngioDynamics
Q4 Net sales of $93.4 million, up 3% year-over-yearQ4 GAAP loss per share of $1.21, inclusive of a one-time tax asset write down of $40.1 million; Non-GAAP adjusted EPS of $0.19, up 37%...
AngioDynamics to Rep
AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
29 juin 2016 06h00 HE | AngioDynamics
ALBANY, N.Y., June 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Report
AngioDynamics Reports Fiscal 2016 Third Quarter Results
07 avr. 2016 16h01 HE | AngioDynamics
Net sales of $87.4 million, up 1% year-over-yearGAAP earnings per share of $0.02; Non-GAAP adjusted EPS of $0.15, up 25% year-over-yearOperating cash generation of $12.4 millionFY2016 financial...
AngioDynamics Appoin
AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
04 avr. 2016 08h00 HE | AngioDynamics
ALBANY, N.Y., April 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Rep
AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
29 mars 2016 06h30 HE | AngioDynamics
ALBANY, N.Y., March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics and Me
AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
10 mars 2016 06h30 HE | AngioDynamics
ALBANY, N.Y., March 10, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...